A detailed history of Fruth Investment Management transactions in Viatris Inc stock. As of the latest transaction made, Fruth Investment Management holds 40,470 shares of VTRS stock, worth $506,684. This represents 0.12% of its overall portfolio holdings.

Number of Shares
40,470
Previous 41,970 3.57%
Holding current value
$506,684
Previous $446,000 5.16%
% of portfolio
0.12%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$10.32 - $12.13 $15,480 - $18,195
-1,500 Reduced 3.57%
40,470 $469,000
Q2 2024

Jul 18, 2024

SELL
$10.05 - $12.02 $1,005 - $1,202
-100 Reduced 0.24%
41,970 $446,000
Q4 2023

Jan 18, 2024

BUY
$8.77 - $10.85 $1,754 - $2,170
200 Added 0.48%
42,070 $455,000
Q3 2023

Oct 10, 2023

SELL
$9.59 - $11.35 $1,918 - $2,270
-200 Reduced 0.48%
41,870 $412,000
Q4 2022

Jan 17, 2023

SELL
$8.72 - $11.56 $9,592 - $12,716
-1,100 Reduced 2.55%
42,070 $468,000
Q3 2022

Oct 13, 2022

SELL
$8.48 - $11.13 $424 - $556
-50 Reduced 0.12%
43,170 $367,000
Q2 2022

Jul 19, 2022

BUY
$9.95 - $12.27 $199 - $245
20 Added 0.05%
43,220 $474,000
Q1 2022

Apr 12, 2022

BUY
$9.81 - $15.4 $34,335 - $53,900
3,500 Added 8.82%
43,200 $470,000
Q4 2021

Jan 14, 2022

BUY
$12.09 - $14.68 $2,115 - $2,569
175 Added 0.44%
39,700 $537,000
Q3 2021

Oct 12, 2021

BUY
$13.25 - $15.13 $15,900 - $18,156
1,200 Added 3.13%
39,525 $535,000
Q2 2021

Jul 19, 2021

BUY
$12.97 - $16.15 $12,970 - $16,149
1,000 Added 2.68%
38,325 $547,000
Q1 2021

Apr 14, 2021

BUY
$13.59 - $18.54 $50,119 - $68,375
3,688 Added 10.96%
37,325 $521,000
Q4 2020

Jan 13, 2021

BUY
$14.3 - $18.74 $481,009 - $630,357
33,637 New
33,637 $630,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Fruth Investment Management Portfolio

Follow Fruth Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.